How should I interpret elevated ferritin, elevated serum iron, high transferrin saturation, and low unsaturated iron‑binding capacity in a patient currently taking oral iron?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Iron Overload from Oral Iron Supplementation

Stop oral iron immediately—these findings indicate iron overload, not iron deficiency. With transferrin saturation of 86% (markedly elevated above the 50-55% threshold), elevated serum iron (151), low UIBC (25), and elevated ferritin (246), this patient has clear biochemical evidence of excessive iron accumulation despite taking oral iron supplementation 1, 2.

Understanding These Results

Your patient's iron studies reveal a dangerous pattern:

  • Transferrin saturation of 86% is severely elevated (normal <45-50%). This means iron is saturating nearly all available transferrin binding sites, creating risk for toxic non-transferrin-bound iron (NTBI) in circulation 3
  • Low UIBC of 25 confirms there is minimal capacity to safely bind additional iron
  • Elevated serum iron of 151 combined with the above creates a state where iron cannot be safely transported
  • Ferritin of 246, while not extremely high, is elevated and reflects increased iron stores

Primary Concern: Hereditary Hemochromatosis

This pattern strongly suggests hereditary hemochromatosis (HH), particularly HFE-related hemochromatosis. The combination of transferrin saturation >55% with elevated ferritin is the classic phenotypic presentation 1, 2.

Immediate Next Steps:

  1. Discontinue oral iron supplementation immediately—continuing iron will worsen tissue iron deposition

  2. Order HFE genetic testing for C282Y and H63D mutations:

    • C282Y homozygosity is present in ~90% of HH cases 2
    • Transferrin saturation ≥50% in males or ≥40% in females with elevated ferritin warrants genetic testing 4
  3. Assess for secondary causes if genetic testing is negative:

    • Liver disease (check AST, ALT, hepatitis panel)
    • Chronic hemolytic anemia
    • Ineffective erythropoiesis (myelodysplastic syndrome, thalassemia)
    • Excessive dietary iron or supplementation

Risk Stratification

The ferritin level of 246 ng/mL places this patient at low risk for cirrhosis (ferritin <1000 ng/mL has negative predictive value for cirrhosis) 2. However, the extremely elevated transferrin saturation indicates ongoing excessive iron absorption that will lead to progressive organ damage if untreated.

Clinical Implications:

  • Cardiac risk: Iron overload causes myocardial dysfunction 5
  • Hepatic risk: Progressive fibrosis leading to cirrhosis and hepatocellular carcinoma 1, 2
  • Endocrine dysfunction: Diabetes, hypogonadism 2
  • Mortality: Transferrin saturation >55% is associated with increased all-cause mortality (hazard ratio 1.60) 2

Diagnostic Workup

Beyond genetic testing, consider:

  • Liver function tests (AST, ALT) to assess hepatic involvement
  • Fasting glucose or HbA1c to screen for diabetes
  • Liver MRI (T2)* if ferritin rises or genetic testing confirms HH—provides non-invasive quantification of hepatic iron concentration 1, 5
  • Liver biopsy is no longer routinely needed with genetic confirmation, but consider if ferritin >1000 ng/mL to assess for cirrhosis 1

Management if Hemochromatosis Confirmed

Therapeutic phlebotomy is the treatment of choice 2:

  • Initial phase: Weekly phlebotomy (500 mL) until ferritin <50 ng/mL
  • Maintenance: Periodic phlebotomy to maintain ferritin 50-100 ng/mL and transferrin saturation <50%
  • Patients may be eligible to donate blood through specialized programs 4

Critical Pitfall to Avoid

Do not assume this is "functional iron deficiency" requiring more iron. The extremely high transferrin saturation (86%) definitively rules out iron deficiency—whether absolute or functional 6. In functional iron deficiency (seen in chronic kidney disease patients on erythropoietin), transferrin saturation is typically <20%, not >80% 6.

The oral iron supplementation this patient has been taking is contraindicated and harmful in the setting of iron overload. Even in patients with inflammatory conditions where ferritin can be elevated, a transferrin saturation of 86% cannot be explained by inflammation alone 6, 7.

Monitoring After Iron Cessation

Recheck iron studies in 3 months after stopping oral iron:

  • If transferrin saturation remains >50-55% with elevated ferritin, this confirms endogenous iron overload requiring treatment
  • If values normalize, consider whether excessive supplementation was the sole cause (though less likely given the severity)

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.